Attending Physician
Active Chart · MRN SYN-1017
34 y/o F · Anaphylaxis to ceftriaxone
Encounter timeline and laboratory review
Linked visit history and responsible clinicians.
Anaphylaxis to ceftriaxone · Dr. Kevin Marsh
Started Mar 6, 2026, 4:00 PM
Recent resulted values for the active encounter.
| Collected | Test | Value | Reference |
|---|---|---|---|
| Mar 6, 2026, 4:30 PM | Lactate | 2.8 mmol/L | 0.5-2.0 |
| Mar 6, 2026, 4:30 PM | WBC | 11.2 K/uL | 4.0-10.5 |
| Mar 6, 2026, 4:30 PM | Tryptase | 28.4 ng/mL | <11.4 |
PROGRESS · RN M. Torres · Mar 6, 2026, 4:15 PM
Patient developed urticaria, lip/tongue swelling, and audible wheezing within 5 minutes of ceftriaxone infusion start. Drug stopped immediately. IM epinephrine 0.3 mg administered to right thigh. BP 78/42 then 96/64 post-epi.
Progress and clinical documentation
PROGRESS · RN M. Torres · Mar 6, 2026, 4:15 PM
Patient developed urticaria, lip/tongue swelling, and audible wheezing within 5 minutes of ceftriaxone infusion start. Drug stopped immediately. IM epinephrine 0.3 mg administered to right thigh. BP 78/42 then 96/64 post-epi.
Medication, lab, and imaging entry
LAB · Mar 6, 2026, 4:20 PM
Parameters: STAT
Rationale: Confirm anaphylaxis diagnosis.
Finalize documentation and orders
Signing this visit finalizes notes and promotes all remaining draft or pending orders to signed.